Journal
NATURE REVIEWS MICROBIOLOGY
Volume 21, Issue 1, Pages 51-64Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41579-022-00770-5
Keywords
-
Categories
Ask authors/readers for more resources
EBV plays a significant role in the development of multiple sclerosis (MS) through the reprogramming of infected B lymphocytes and the chronic presentation of viral antigens. Understanding how EBV contributes to MS may also provide insights into the relationship between EBV and cancer.
Epstein-Barr virus (EBV) is a ubiquitous human lymphotropic herpesvirus with a well-established causal role in several cancers. Recent studies have provided compelling epidemiological and mechanistic evidence for a causal role of EBV in multiple sclerosis (MS). MS is the most prevalent chronic inflammatory and neurodegenerative disease of the central nervous system and is thought to be triggered in genetically predisposed individuals by an infectious agent, with EBV as the lead candidate. How a ubiquitous virus that typically leads to benign latent infections can promote cancer and autoimmune disease in at-risk populations is not fully understood. Here we review the evidence that EBV is a causal agent for MS and how various risk factors may affect EBV infection and immune control. We focus on EBV contributing to MS through reprogramming of latently infected B lymphocytes and the chronic presentation of viral antigens as a potential source of autoreactivity through molecular mimicry. We consider how knowledge of EBV-associated cancers may be instructive for understanding the role of EBV in MS and discuss the potential for therapies that target EBV to treat MS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available